Strategic Debut Enclara Healthcare was acquired by Humana in December 2019, signaling potential alignment with large payer ecosystems and access to established distribution channels for hospice pharmacy and PBM services.

Payer Alignment The Humana partnership and acquisition history suggest an opportunity to engage with large health plans and value-based care initiatives, positioning Enclara as a bridge between payers and complex care patient populations.

Care Delivery Focus Specialization in simplifying care delivery for complex patient populations indicates sales potential for integrated care management platforms, workflows, and technology that reduce cost and improve patient experience in hospices and similar settings.

Tech Enablement With a tech stack including Power Automate, MySQL, and HIPAA-compliant tools, there is room to upsell automation, data integration, and analytics solutions that enhance care coordination and compliance for healthcare organizations.

Market Position As a smaller player with revenue in the sub-million range and a connection to large incumbents, there is an opportunity to target mid-market health systems and regional payers looking to augment hospice PBM capabilities and value-based care programs.